Verapamil induces upregulation of P-glycoprotein expression on human monocyte derived dendritic cells

Immunological Investigations

Volumn 35, Issue 1, 2006, Pages 1-18

  Ishri, Raj K ^a   Menzies, Scott ^a,b   Halliday, Gary M ^a,c  

^a ROYAL PRINCE ALFRED HOSPITAL   (Australia)

^b University of Sydney   (Australia)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dendritic cells; P glycoprotein; Verapamil

Indexed keywords

B7 ANTIGEN; CD14 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; EPIRUBICIN; GLYCOPROTEIN P; GLYCOPROTEIN P 15095; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4E3; RHODAMINE 123; T6 ANTIGEN; UNCLASSIFIED DRUG; VERAPAMIL;

ANTIGEN PRESENTING CELL; ARTICLE; CELL IMMORTALIZATION; CELL MATURATION; CELL MIGRATION; CELL STRAIN E10; CELL STRAIN K 562; CELL STRAIN MOLT 4; CELL STRAIN THP 1; CELL STRAIN U937; CONTROLLED STUDY; CULTURE MEDIUM; DAUDI CELL; DENDRITIC CELL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INFLAMMATION; MACROPHAGE; MONOCYTE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; STREPTOCOCCUS PYOGENES; T LYMPHOCYTE; UPREGULATION;

ANTIBODIES, MONOCLONAL; CALCIUM CHANNEL BLOCKERS; CELL DIFFERENTIATION; CELL LINE, TUMOR; DENDRITIC CELLS; HEMATOLOGIC NEOPLASMS; HUMANS; MACROPHAGES; MONOCYTES; P-GLYCOPROTEIN; RHODAMINE 123; STREPTOCOCCUS PYOGENES; UP-REGULATION; VERAPAMIL;

EID: 33644990602     PISSN: 08820139     EISSN: 15324311     Source Type: Journal    
DOI: 10.1080/08820130500496746     Document Type: Article

References (32)

1. Abbaszadegan, M. R., Cress, A. E., Futscher, B. W., Bellamy, W. T., Dalton, W. S. (1996a). Evidence for cytoplasmic P-glycoprotein location associated with increased multidrug resistance and resistance to chemosensitizers. Cancer Res. 56:5435-5442.
2. Abbaszadegan, M. R., Foley, N. E., Gleason-Guzman, M. C., Dalton, W. S. (1996b). Resistance to the chemosensitizer verapamil in a multi-drug-resistant (MDR) human multiple myeloma cell line. Internat. J. Can. 66:506-514.
3. Bosch, I., Dunussi-Joannopoulos, K., Wu, R. L., Furlong, S. T., Croop, J. (1997). Phosphatidylcholine and phosphatidylethanolamine behave as substrates of the human MDR1 P-glycoprotein. Biochemistry 36:5685-5694.
4. Bucana, C. D., Giavazzi, R., Nayar, R., O'Brian, C. A., Seid, C., Earnest, L. E., Fan, D. (1990). Retention of vital dyes correlates inversely with the multidrug-resistant phenotype of adriamycin selected murine fibrosarcoma variants. Exp. Cell Res. 190:69-95.
5. Chao, D., Bahl, P., Houlbrook, S., Hoy, L., Harris, A., Austyn, J. M. (1999). Human cultured dendritic cells show differential sensitivity to chemotherapy agents as assessed by the MTS assay. Brit. J. Can. 81:1280-1284.
6. Cho, C. W., Liu, Y., Yan, X., Henthorn, T., Ng, K. Y. (2000). Carrier-mediated uptake of rhodamine 123: implications on its use for MDR research. Biochem. Biophys. Res. Comm. 279:124-130.
7. Drach, D., Zhao, S., Drach, J., Mahadevia, R., Gattringer, C., Huber, H., Andreeff, M. (1992). Subpopulations of normal peripheral blood and bone marrow cells express a functional multidrug resistant phenotype. Blood 80:2729-34.
8. Higgins, C. F. (1995). P-glycoprotein and cell volume-activated chloride channels. J. Bioenerg. Biomemb. 27:63-70.
9. Higgins, C. F., Linton, K. J. (2001). Structural biology. The xyz of ABC transporters. Science. 293:1782-1784.
10. Ishri, R. K., Menzies, S., Hersy, P., Halliday, G. M. (2004). Rapid downregulation of antigen processing enzymes in ex vivo generated human monocyte derived dendritic cells occue endogenously in extended cultures. Immunol. Cell Biol. 82:239-246.
11. Janeway, C. A. J., Travers, P., Walport, M., Capra, J. D. (1999). Immunobiology. Current Biology Publications. 4th ed., London: Elsevier Science Ltd/Garland Publishing.
12. Kanto, T., Kalinski, P., Hunter, O. C., Lotze, M. T., Amoscato, A. A. (2001). Ceramide mediates tumor-induced dendritic cell apoptosis. J. Immunol. 167:3773-3784.
13. Laupeze, B., Amiot, L., Bertho, N., Grosset, J. M., Lehne, G., Fauchet, R., Fardel, O. (2001). Differential expression of the efflux pumps P-glycoprotein and multidrug resistance-associated protein in human monocyte-derived dendritic cells. Human Immunol. 62:1073-1080.
14. Lautier, D., Canitrot, Y., Salmon, J. M. (1994). Effects of vinblastine, colchicine, and verapamil on rhodamine 123 accumulation in human P-glycoprotein-positive leukemia cells. Anticancer Res. 14:2589-2595.
15. Lavie, Y., Fiucci, G., Czarny, M., Liscovitch, M. (1999). Changes in membrane micro-domains and caveolae constituents in multidrug-resistant cancer cells. Lipids 34:S57-63.
16. Liu, Y. Y., Han, T. Y., Giuliano, A. E., Cabot, M. C. (1999). Expression of glucosylceramide synthase, converting ceramide to glucosylceramide, confers adriamycin resistance in human breast cancer cells. J. Biol. Chem. 274:1140-1146.
17. Liu, Y. Y., Han, T. Y., Giuliano, A. E., Hansen, N., Cabot, M. C. (2000). Uncoupling ceramide glycosylation by transfection of glucosylceramide synthase antisense reverses adriamycin resistance. J. Biol. Chem. 275:7138-7143.
18. Ludescher, C., Thaler, J., Drach, D., Drach, J., Spitaler, M., Gattringer, C., Huber, H., Hofmann, J. (1992). Detection of activity of P-glycoprotein in human tumour samples using rhodamine 123. Brit. J. Haematol. 82:161-168.
19. Marks, D. C., Davey, M. W., Davey, R. A., Kidman, A. D. (1993). Differentiation and multidrug resistance in response to drug treatment in the K562 human leukaemia cell line. Brit. J. Haematol. 84:83-89.
20. Muller, W. A., Randolph, G. J. (1999). Migration of leukocytes across endothelium and beyond: molecules involved in the transmigration and fate of monocytes. J. Leuk. Biol. 66:698-704.
21. Murray, R. K., Mayes, P. A., Rodwell, V. W., Granner, D. K. (2000). Harper's Biochemistry. 26th ed., McGraw-Hill Medical Publishing Division: New York.
22. Nelson, E. J., Zinkin, N. T., Hinkle, P. M. (1998). Fluorescence methods to assess multidrug resistance in individual cells. Cancer Chemother. Pharmacol. 42:292-299.
23. Pinedo, H. M., Giaccone, G. (1995). P-Glycoprotein - a marker of cancer-cell behaviour. [Editorial].N. Engl. J. Mal. 333:1417-1419.
24. Randolph, G. J., Beaulieu, S., Lebecque, S., Steinman, R. M., Muller, W. A. (1998). Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking. [Report]. Science 282:480-483.
25. Randolph, G. J., Beaulieu, S., Pope, M., Sugawara, I., Hoffman, L., Steinman, R. M., Muller, W. A. (1998). A physiologic function for p-glycoprotein (MDR-1) during the migration of dendritic cells from skin via afferent lymphatic vessels. Proc. Natl. Acad. Sci. 95:6924-6929.
26. Sallusto, F., Nicolo, C., De Maria, R., Corinti, S., Testi, R. (1996). Ceramide inhibits antigen uptake and presentation by dendritic cells. J. Ex. Med. 184:2411-2416.
27. Schinkel, A. H., Borst, P. (1991). Multidrug resistance mediated by P-glycoproteins. Semin. Can. Biol. 2:213-226.
28. Schroeijers, A. B., Reurs, A. W., Scheffer, G. L., Stam, A. G., de Jong, M. C., Rustemeyer, T., Wiemer, E. A., de Gruijl, T. D., Scheper, R. J. (2002). Up-regulation of drug resistance-related vaults during dendritic cell development. J. Immunol. 168:1572-1578.
29. Smital, T., Sauerborn, R., Pivcevic, B., Krca, C., Kurelec, B. (2000). Interspecies differences in P-glycoprotein mediated activity of multixenobiotic resistance mechanism in several marine and freshwater invertebrates. Comp. Biochem. Physio. C: Comp. Pharmacol. Toxicol. 126:175-186.
30. Su, G. M., Davey, M. W., Davey, R. A., Kidman, A. D. (1994). Development of extended multidrug resistance in HL60 promyelocytic leukaemia cells. Brit. J. Haematol. 88:566-574.
31. Tsuruo, T., Lida, H., Tsukagoshi, S., Sakurai, Y. (1981). Overcoming of vincristine resistance of P388 leukaemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res. 41:1967-1972.
32. van Helvoort, A., Giudici, M. L., Thielemans, M., van Meer, G. (1997). Transport of sphingomyelin to the cell surface is inhibited by brefeldin A and in mitosis, where C6-NBD-sphingomyelin is translocated across the plasma membrane by a multidrug transporter activity. J. Cell Sci. 110:75-83.